<DOC>
	<DOCNO>NCT02762214</DOCNO>
	<brief_summary>Prospective multicentric randomize trial evaluate role uterine manipulator laparoscopic/robotic total hysterectomy treatment early stage G1 - G2 endometrial cancer ( International Federation Gynecology Obstetrics - FIGO stag IA-IB ) .</brief_summary>
	<brief_title>Role Uterine Manipulator Hysterectomy - Ro.Man.HY</brief_title>
	<detailed_description>This multicentric prospective randomize Phase III trial aim verify use uterine manipulator laparoscopic/robotic treatment early stage endometrial cancer influence impact peritoneal cytology lymph vascular space invasion ( LVSI ) outcomes term perioperative oncological ( disease free survival - DFS , overall survival - OS ) outcomes .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>For patient Age &gt; 18 &lt; 80 year Patient 's informed consent American Society Anesthesiologists : &lt; class III IV No actual pregnancy Body Mass Index ( BMI ) â‰¤ 35 For disease Early stage endometrial cancer ( IAIB ) Endometrioid histotype ( G1G2 ) For patient Age &gt; 18 &lt; 80 Actual pregnancy Previous gynecological cancer For disease Type II endometrial cancer histotype Grade 3 endometrial cancer Advanced stage endometrial cancer ( II IV ) Previous radiotherapy pelvic field Uterine size large conform 12 week gestation 9 cm horizontal Necessity laparotomic procedure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Uterin manipulator</keyword>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Robotic</keyword>
</DOC>